Puma Biotech (PBYI) Licensing Partner CANbridge Pharmaceuticals Receives Registration Approval in Hong Kong for NERLYNX

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to Puma Biotech (PBYI) Licensing Partner CANbridge Pharmaceuticals Receives Registration Approval in Hong Kong for NERLYNX
PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) Delayed: 7.33 +0.10 (1.38%)
Previous Close $7.23    52 Week High $82.81 
Open $7.26    52 Week Low $19.74 
Day High $7.33    P/E N/A 
Day Low $6.98    EPS $-2.16 
Volume 260,994